immatics raises final tranche of Series D fundraising
immatics biotechnologies, a clinical-stage biopharmaceutical has completed a Series D financing round. The funding was supported by existing investors including dievini Hopp Biotech holding, Wellington Partners, and AT Impf GmbH and others.
16 July 2014•4 mins read
